APO RESEARCH · REPORT
PNH and aHUS
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
Product & engineering
Understand the product.
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
Selected research
Industry Research
PNH and aHUS Industry Research Report 2026
Market perspective
PNH and aHUS, both are extremely rare and genetic diseases. Due to PNH, destruction of red blood cells of a person occurs quite sooner than it should. It is an acquired hematopoietic stem cell disorder. Hematopoietic stem cells are developed in bone marrow and eventually turn into red blood cells, white blood cells and platelets. A person with PNH has some defected hematopoietic cells which create defective red blood cells. These defective cells are highly susceptible to premature destruction by the complement system. aHUS is a disorders in which blood clots are formed in small blood vessels throughout the body. TMA can lead to heart stroke, attack, kidney failure and death.
United States is the largest consumption place, with a consumption market share nearly 52.1% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 26.2%.
Report Scope
Read the full market overview
This report quantifies the global PNH and aHUS market in terms of revenue (US$ million) and, where applicable, service volume (Unit), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Unit) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to PNH and aHUS.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
PNH and aHUS Market by Company
Alexion Pharmaceuticals
Alnylam Pharmaceuticals
Omeros Corporation
PNH and aHUS Segment by Type
Soliris
Ultomiris
PNH and aHUS Segment by Application
PNH
aHUS
PNH and aHUS Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PNH and aHUS market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of PNH and aHUS and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PNH and aHUS.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of PNH and aHUS companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Soliris
- Ultomiris
Applications
- PNH
- aHUS
Companies covered
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Omeros Corporation
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 PNH and aHUS by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Soliris
- 2.2.3 Ultomiris
- 2.3 PNH and aHUS by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 PNH
- 2.3.3 aHUS
- 2.4 Assumptions and Limitations
3 PNH and aHUS Breakdown Data by Type
- 3.1 Global PNH and aHUS Historic Market Size by Type (2021-2026)
- 3.2 Global PNH and aHUS Forecasted Market Size by Type (2027-2032)
4 PNH and aHUS Breakdown Data by Application
- 4.1 Global PNH and aHUS Historic Market Size by Application (2021-2026)
- 4.2 Global PNH and aHUS Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global PNH and aHUS Market Perspective (2021-2032)
- 5.2 Global PNH and aHUS Growth Trends by Region
- 5.2.1 Global PNH and aHUS Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 PNH and aHUS Historic Market Size by Region (2021-2026)
- 5.2.3 PNH and aHUS Forecasted Market Size by Region (2027-2032)
- 5.3 PNH and aHUS Market Dynamics
- 5.3.1 PNH and aHUS Industry Trends
- 5.3.2 PNH and aHUS Market Drivers
- 5.3.3 PNH and aHUS Market Challenges
- 5.3.4 PNH and aHUS Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top PNH and aHUS Players by Revenue
- 6.1.1 Global Top PNH and aHUS Players by Revenue (2021-2026)
- 6.1.2 Global PNH and aHUS Revenue Market Share by Players (2021-2026)
- 6.2 Global PNH and aHUS Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of PNH and aHUS Head Office and Area Served
- 6.4 Global PNH and aHUS Players, Product Type & Application
- 6.5 Global PNH and aHUS Manufacturers Established Date
- 6.6 Global PNH and aHUS Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America PNH and aHUS Market Size (2021-2032)
- 7.2 North America PNH and aHUS Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America PNH and aHUS Market Size by Country (2021-2026)
- 7.4 North America PNH and aHUS Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe PNH and aHUS Market Size (2021-2032)
- 8.2 Europe PNH and aHUS Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe PNH and aHUS Market Size by Country (2021-2026)
- 8.4 Europe PNH and aHUS Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific PNH and aHUS Market Size (2021-2032)
- 9.2 Asia-Pacific PNH and aHUS Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific PNH and aHUS Market Size by Country (2021-2026)
- 9.4 Asia-Pacific PNH and aHUS Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America PNH and aHUS Market Size (2021-2032)
- 10.2 South America PNH and aHUS Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America PNH and aHUS Market Size by Country (2021-2026)
- 10.4 South America PNH and aHUS Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa PNH and aHUS Market Size (2021-2032)
- 11.2 Middle East & Africa PNH and aHUS Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa PNH and aHUS Market Size by Country (2021-2026)
- 11.4 Middle East & Africa PNH and aHUS Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Alexion Pharmaceuticals
- 12.1.1 Alexion Pharmaceuticals Company Information
- 12.1.2 Alexion Pharmaceuticals Business Overview
- 12.1.3 Alexion Pharmaceuticals Revenue in PNH and aHUS Business (2021-2026)
- 12.1.4 Alexion Pharmaceuticals PNH and aHUS Product Portfolio
- 12.1.5 Alexion Pharmaceuticals Recent Developments
- 12.2 Alnylam Pharmaceuticals
- 12.2.1 Alnylam Pharmaceuticals Company Information
- 12.2.2 Alnylam Pharmaceuticals Business Overview
- 12.2.3 Alnylam Pharmaceuticals Revenue in PNH and aHUS Business (2021-2026)
- 12.2.4 Alnylam Pharmaceuticals PNH and aHUS Product Portfolio
- 12.2.5 Alnylam Pharmaceuticals Recent Developments
- 12.3 Omeros Corporation
- 12.3.1 Omeros Corporation Company Information
- 12.3.2 Omeros Corporation Business Overview
- 12.3.3 Omeros Corporation Revenue in PNH and aHUS Business (2021-2026)
- 12.3.4 Omeros Corporation PNH and aHUS Product Portfolio
- 12.3.5 Omeros Corporation Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst